Nifedipine Tablet, Extended Release
Product Images NDC 70518-2679

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 70518-2679). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nifedipine 30mg 70518 2679 00

Nifedipine 30 mg extended-release oral tablets packaging label showing quantity of 30 tablets. The label includes storage instructions, a warning to swallow tablets whole, and repackaging details by RemedyRepack Inc. The manufacturer is Ingenus, Fairfield, NJ. The NDC number 70518-2679 is also displayed along with a QR code.*

FDA Label Image

01 (Image 01)

Chemical structure diagram of nifedipine, showing its molecular composition with rings, nitro, and methyl groups as part of the structure.*

FDA Label Image

02 (Image 02)

A data table comparing the percentage of adverse effects reported in two groups: patients taking Nifedipine extended-release tablets (30 mg) and those taking placebo. Adverse effects include headache, fatigue, dizziness, constipation, and nausea, with corresponding percentages for each group.*

FDA Label Image

03 (Image 03)

A table presenting adverse effect percentages for Nifedipine extended-release tablets (30 mg) compared to placebo. It lists side effects such as dizziness, flushing, headache, weakness, nausea, muscle cramps, peripheral edema, nervousness, palpitations, dyspnea, and nasal congestion with corresponding incidence rates for both groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.